HIV and AIDS News - ScienceDaily
2 days ago · HIV and AIDS information and facts. Read latest medical articles and view educational videos on AIDS and HIV symptoms and treatments. Stay informed about new developments on the...
Science’s 2024 Breakthrough of the Year: Opening the door to a
Dec 12, 2024 · Many HIV/AIDS researchers are now hopeful that the drug, lenacapavir, will powerfully drive down global infection rates when used as pre-exposure prophylaxis (PrEP). “It has the potential, if we can do it right, which means going big and getting it out there,” says Linda-Gail Bekker, an infectious disease specialist at the University of ...
HIV News - Aids News, HIV Research News, Aids Research ... - Medical Xpress
5 days ago · Several giant US and international groups focused on fighting HIV and AIDS on Tuesday unveiled a plan to swiftly provide affordable access to a possibly "game-changing" HIV prevention drug in...
New HIV drug can only offer hope of ending AIDS if all have …
GENEVA, 10 July 2024— UNAIDS has welcomed the release of Gilead Sciences’ trial results on the injectable long-acting HIV medicine Lenacapavir for HIV prevention. The result “provides hope of accelerating efforts to end AIDS”, UNAIDS says, “but only if Gilead ensures that all people who need it can have access to this game-changing ...
HIV/AIDS News | NIH - Clinicalinfo
Dec 19, 2024 · Stay up-to-date on HIV and AIDS-related news. The Perinatal HIV Clinical Guidelines updated three sections that include: Infant Feeding, Diagnosis of HIV Infection, and Antiretroviral Management.
Researchers a step closer to a cure for HIV | ScienceDaily
Mar 26, 2024 · A new study shows virus-like particle can effectively 'shock and kill' latent HIV reservoir in those living with chronic HIV.
AIDS 2024: Research Updates, HIV Criminalization Laws, and AI …
Jul 25, 2024 · HIV.gov continued daily coverage of AIDS 2024. Below are recaps of four livestreamed conversations: Brian Minalga, M.S.W., deputy director of the NIH-supported Office of HIV/AIDS Network Coordination, spoke with Carl Dieffenbach, Ph.D., director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases.
Researchers Investigate Potential Treatment for Eliminating HIV
Dec 20, 2024 · HIV-infected macrophages can also persist in the brain during antiretroviral treatment, making them a source of long-lasting HIV infection. Because macrophages help spread and maintain HIV infection, targeting these cells could be a way to successfully eliminate HIV from the brain. BLZ945 is a small molecule capable of entering into the brain.
A seventh case of HIV cure reported at AIDS 2024
Jul 25, 2024 · During the 25th International AIDS Conference (AIDS 2024), being held in Munich, Germany, a new case of long HIV remission was reported and fuels optimism for an eventual HIV cure. In 2007, Timothy Brown, the so-called first Berlin patient, was the first person to be considered cured of HIV.
HIV/AIDS News | NIH - National Institutes of Health
Nov 21, 2024 · The Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) updated the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV. For a comprehensive list of recent updates, please see What's New in the Guidelines.